BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8742553)

  • 1. Some design, measurement, and analysis pitfalls in drug abuse prevention research and how to avoid them: let your model be your guide.
    Collins LM
    NIDA Res Monogr; 1994; 139():95-114. PubMed ID: 8742553
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothesis formulation and testing in substance use prevention research.
    Hansen WB
    NIDA Res Monogr; 1994; 139():59-74. PubMed ID: 8742551
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
    Hser YI; Anglin MD
    NIDA Res Monogr; 1991; 113():67-93. PubMed ID: 1762644
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome measurement issues in drug abuse prevention studies.
    Dwyer JH; MacKinnon DP
    NIDA Res Monogr; 1991; 107():183-94. PubMed ID: 1922305
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug prevention research with Hispanic populations: theoretical and methodological issues and a generic structural model.
    Castro FG; Harmon MP; Coe K; Tafoya-Barraza HM
    NIDA Res Monogr; 1994; 139():203-33. PubMed ID: 8742558
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction for the design effect in school-based substance use and abuse prevention research: sample size requirements and analysis considerations.
    Dielman TE
    NIDA Res Monogr; 1994; 139():115-25. PubMed ID: 8742554
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of mediating variables in prevention and intervention research.
    MacKinnon DP
    NIDA Res Monogr; 1994; 139():127-53. PubMed ID: 8742555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A framework for drug abuse prevention research.
    Bukoski WJ
    NIDA Res Monogr; 1991; 107():7-28. PubMed ID: 1922313
    [No Abstract]   [Full Text] [Related]  

  • 9. Designing and analyzing studies of onset, cessation, and relapse: using survival analysis in drug abuse prevention research.
    Singer JD; Willett JB
    NIDA Res Monogr; 1994; 142():196-263. PubMed ID: 9243538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying multilevel analytic strategies in adolescent substance use prevention research.
    Palmer RF; Graham JW; White EL; Hansen WB
    Prev Med; 1998; 27(3):328-36. PubMed ID: 9612823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target populations and interventions in prevention research: what is high risk?
    Pentz MA
    NIDA Res Monogr; 1994; 139():75-93. PubMed ID: 8742552
    [No Abstract]   [Full Text] [Related]  

  • 12. New statistical methods for substance use prevention research.
    Collins LM; Seitz LA
    NIDA Res Monogr; 1994; 142():1-12. PubMed ID: 9243531
    [No Abstract]   [Full Text] [Related]  

  • 13. Modeling of intervention effects.
    Bentler PM
    NIDA Res Monogr; 1991; 107():159-82. PubMed ID: 1922304
    [No Abstract]   [Full Text] [Related]  

  • 14. Universal school-based substance abuse prevention programs: Modeling targeted mediators and outcomes for adolescent cigarette, alcohol and marijuana use.
    Stephens PC; Sloboda Z; Stephens RC; Teasdale B; Grey SF; Hawthorne RD; Williams J
    Drug Alcohol Depend; 2009 Jun; 102(1-3):19-29. PubMed ID: 19362433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.
    Kendler KS; Prescott CA; Myers J; Neale MC
    Arch Gen Psychiatry; 2003 Sep; 60(9):929-37. PubMed ID: 12963675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse prevention intervention research with Hispanic populations.
    Castro FG; Barrera M; Pantin H; Martinez C; Felix-Ortiz M; Rios R; Lopez VA; Lopez C
    Drug Alcohol Depend; 2006 Sep; 84 Suppl 1():S29-42. PubMed ID: 16787713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring youth outcomes from alcohol and drug treatment.
    Brown SA
    Addiction; 2004 Nov; 99 Suppl 2():38-46. PubMed ID: 15488104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing effectiveness of drug abuse prevention: implementation issues relevant to long-term effects and replication.
    Hawkins JD; Abbott R; Catalano RF; Gillmore MR
    NIDA Res Monogr; 1991; 107():195-212. PubMed ID: 1922306
    [No Abstract]   [Full Text] [Related]  

  • 19. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological issues in the assessment of substance use phenotypes.
    Neale MC; Aggen SH; Maes HH; Kubarych TS; Schmitt JE
    Addict Behav; 2006 Jun; 31(6):1010-34. PubMed ID: 16723188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.